ExodusPoint Capital Management’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.34M | Buy |
+172,552
| New | +$2.34M | 0.02% | 637 |
|
2024
Q3 | – | Sell |
-274,316
| Closed | -$3.21M | – | 1768 |
|
2024
Q2 | $3.21M | Buy |
274,316
+152,110
| +124% | +$1.78M | 0.02% | 510 |
|
2024
Q1 | $1.58M | Buy |
122,206
+48,266
| +65% | +$623K | 0.01% | 694 |
|
2023
Q4 | $636K | Sell |
73,940
-85,501
| -54% | -$735K | ﹤0.01% | 896 |
|
2023
Q3 | $1.52M | Sell |
159,441
-34,084
| -18% | -$324K | 0.01% | 751 |
|
2023
Q2 | $3.3M | Buy |
193,525
+12,213
| +7% | +$208K | 0.03% | 524 |
|
2023
Q1 | $2.84M | Buy |
+181,312
| New | +$2.84M | 0.02% | 653 |
|